rs1555516985
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_004320.6(ATP2A1):c.1976A>G(p.Asp659Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004320.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2A1 | NM_004320.6 | c.1976A>G | p.Asp659Gly | missense_variant | Exon 15 of 23 | ENST00000395503.9 | NP_004311.1 | |
ATP2A1 | NM_173201.5 | c.1976A>G | p.Asp659Gly | missense_variant | Exon 15 of 22 | NP_775293.1 | ||
ATP2A1 | NM_001286075.2 | c.1601A>G | p.Asp534Gly | missense_variant | Exon 13 of 21 | NP_001273004.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2A1 | ENST00000395503.9 | c.1976A>G | p.Asp659Gly | missense_variant | Exon 15 of 23 | 1 | NM_004320.6 | ENSP00000378879.5 | ||
ATP2A1 | ENST00000357084.7 | c.1976A>G | p.Asp659Gly | missense_variant | Exon 15 of 22 | 2 | ENSP00000349595.3 | |||
ATP2A1 | ENST00000536376.5 | c.1601A>G | p.Asp534Gly | missense_variant | Exon 13 of 21 | 2 | ENSP00000443101.1 | |||
ATP2A1 | ENST00000564732.1 | n.*619A>G | downstream_gene_variant | 5 | ENSP00000457357.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Brody myopathy Uncertain:1
In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a ATP2A1-related disease. This sequence change replaces aspartic acid with glycine at codon 659 of the ATP2A1 protein (p.Asp659Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at